ID   BMC-PDC-019
AC   CVCL_D1GF
DR   Wikidata; Q127380342
RX   PubMed=37707774;
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=37707774).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (PubMed=37707774).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=37707774
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11,12,13
ST   D18S51: 13,14
ST   D19S433: 13,13.2,14,15
ST   D21S11: 29,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 10,11,12
ST   D7S820: 8,10,12
ST   D8S1179: 10,13,14,15
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 15,18,19
ST   TH01: 6,7,8,9
ST   TPOX: 11
ST   vWA: 14,15,16
DI   NCIt; C202133; Transformed EGFR-positive lung adenocarcinoma to small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
RX   PubMed=37707774; DOI=10.1007/s13577-023-00980-w;
RA   Kim M.Y., Jung S.Y., Hong S., Oh S.W., Jin K.N., Kim J.E., Kim J.-S.;
RT   "Establishment and characterization of BMC-PDC-019: a novel
RT   patient-derived cell line of EGFR-mutant pulmonary adenocarcinoma
RT   transformed into small-cell lung cancer.";
RL   Hum. Cell 36:2179-2186(2023).
//